Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining -1.21% today. In the last week its performance is 0.00%, and 13.50% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 7.42, so today’s gain of -1.21% is a significant step towards its target price. The GAP today is therefore -0.43%.
Abbott Laboratories (NYSE:ABT), has a market cap of 61269.6, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 73.90%.
At the current price of 41.68, it has a dividend yield of 2.50%, and its target price is 7.42. This is with a profit margin of 11.10%, and total debt/equity of 0.41. Abbott Laboratories (NYSE:ABT) has a P/E of 31.99, as well as a forward P/E of 16.98.
With a current EPS of 1.3, and a forecasted EPS growth for next year at 11.69%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at -10.30%. For the next five years EPS growth is projected to be 9.61%.
Performance for the year is 4.52%. Since its IPO date on 4/6/1983, the total performance to date is -5.46%.
Volume today for Abbott Laboratories (NYSE:ABT), is 6371400, while its average volume is 9727.18. Whilst the total gain today was -1.21%, it did have a day high of -8.98%.
Volatility for this week has been at 1.15%, and 1.59% for the month. The 52-week low for Abbott Laboratories, ABT has been 17.20%, while the 52-week-high has reached -8.98%.
Looking at its return of investments, which is 7.70%, and its return on assets is 5.60%. Abbott Laboratories (NYSE:ABT) has an operating margin of 14.00%. With a sales growth of 3.20% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is 0.29, and has a current ratio of 1.5 and 1.2 for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 3.33, and the P/S is 2.98, along with a P/B of 2.97. Meanwhile it has a p/cash of 13.81.